Wikidata

(Q39999985)

English

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

scientific article

In more languages

Statements

title
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
main subject
glycobiology
0 references
glucose
0 references
author name string
Songping Han
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
Deborah L Hagan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
Joseph R Taylor
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
Wei Meng
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
Scott A Biller
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
John R Wetterau
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
William N Washburn
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
Jean M Whaley
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
publication date
20 March 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017
page(s)
1723-1729
1 reference
stated in
Europe PubMed Central
PubMed ID
18356408
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39999985&oldid=1882281751"